Transitioning Between Viral & NonViral Platforms to Enhance CAR-T Safety & Durability

• Transitioning from a viral to non-viral platform for a cell therapy
• Overexpression of genes to enhance CAR-T function using a non-viral strategy for pediatric rare disease

Speakers:

Steven Feldman

Site Head & Scientific Director, Laboratory for Cell & Gene Medicine

Stanford GMP Facility